Nuedexta is a one and only commercially marketed formulation, and with the patents just being upheld, there will be no competing drug and no generics until late 2026.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.